Faecal matter transplantation (FMT) has been used in people to treat Clostridium difficile infections and has also been trialled in conditions such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
The researchers believe that FMT offers a potential new option for the treatment of chronic diarrhoea in dogs and the study will investigate whether it contributes to a more rapid resolution of clinical signs. The study is being conducted in association with eight other private practices or universities around the country.
Julien Bazelle, a European Veterinary Specialist in Small Animal Internal Medicine at Davies said: "The goal is to recruit, over a short period of time, canine patients with chronic small intestinal diarrhoea, for a randomised trial in which the cohort receives or not FMT at the time of the initial investigations and prior to any other treatment.”
Dogs aged 6 months to 10 years with a history of chronic small intestinal diarrhoea (+/- other GI signs) are needed to participate in the study. Half of the dogs will receive FMT and the other half will be managed without. FMT will be performed in eligible patients during the sedation for their routine abdominal ultrasound. Transplanted faecal matter will be administered via a retention enema.
To be eligible, dogs must not have received antibiotics, probiotics or steroids recently.
If you have a potentially suitable patient please contact: julien.bazelle@vetspecialists.co.uk or Fergus.Allerton@willows.uk.net
The new, four storey, architecturally-designed clinic is full of natural light and includes calming and spacious staff breakout areas.
By combining a beautiful work environment with seamless technology, the company believes it can transform working conditions and job satisfaction for vet teams.
On the tech side, the Creature Comforts has created a proprietary app which allows triage to be handled online and for staff to work flexibly.
The company says the app also reduces the administrative burden, a contributory factor for staff burnout.
Creature Comforts says most clients subscribe at a cost of £20 per pet per month, giving them unlimited consultations, instant bookings and live chat via the app (as well as annual vaccinations and discounted routine treatments).
This should mean animals are seen more frequently, and conditions can be identified and treated earlier.
Memberships will be capped to control vet team caseload and to ensure a good customer experience.
The company is also addressing Competition and Markets Authority concerns, with prices for routine treatments listed on its website, upfront estimates for procedures, and a business model hinged on unlimited access to expertise (i.e. consultations, instant in-app bookings and live chat) at no extra cost for subscribed members.
Creature Comforts says its vet team benefits from a share of their clinic’s profits, above industry-standard pay, compensated overtime, a well-balanced staffing ratio, manageable working hours and scheduled breaks.
Dr Russell Welsh, COO and co-founder of Creature Comforts, said: “It’s an incredible feeling to see a plan come together in a sector that’s so ripe for transformation.
"We want to bring the passion, joy and fun back to our profession, and this is an opportunity to do things differently and vastly better, with a fresh and carefully-considered business model founded on the principles of health and happiness.
"This is vet care as it should be."
https://www.creaturecomforts.co.uk
The results, in order of number of votes, are:
Elected: Susan Paterson – 3,976 votes
Elected: Mandisa Greene – 3,819 votes
Elected: Neil Smith – 3,544 votes
John Innes – 3,502 votes
David Catlow – 3,310 votes
Matthew Plumtree – 2,677 votes
Iain Richards – 2,635 votes
Karlien Heyrman – 2,487 votes
John Davies – 580 votes
Thomas Lonsdale – 542 votes
Due to the fact that a Legislative Reform Order (LRO) that amends the College’s governance has completed its passage through the House of Commons and House of Lords and is expected to be signed off by the relevant Minister to bring it into law, only the first three candidates are expected to take up their posts on Council at RCVS Day on 13 July 2018.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "I would like to thank all the candidates who stood for Council this year and would like to, in particular, congratulate Susan, Mandisa and Neil for being re-elected to RCVS Council.
"The LRO that is likely to be signed off in due course will reconstitute the makeup of Council – with greater lay and veterinary nursing input – and will also reduce the overall size of Council, including the number of elected members. Because of this only the first three – as opposed to the first six under previous rules – candidates are likely to be taking up a four-year term at RCVS Day 2018. Our commiserations go out to all the unsuccessful candidates, especially in this unusual transitional year, and we thank them for their participation in this year’s election."
The results of the election will be formally declared at this year’s RCVS Day – the College’s Annual General Meeting and awards ceremony – which takes place at the Royal Institute of British Architects on Friday 13 July 2018.
Anthony Chadwick, a referral dermatologist, has teamed up with other experts to offer a series of web-based seminars with the aim of bringing accessible and convenient CPD to vets. 50 VetSurgeon members can attend the webinars for half price. Just enter the word vetsurgeon in the discount box on the site.
The webinars can be viewed from a practice or office and cover key veterinary topics including:
The webinars will be broadcast between 9.00 pm and 10.00 pm in a series running from 22 April to 27 May 2010.
Anthony said: "Many vets don't finish consulting until 7.00 pm and then have evening or family commitments. This can make finding the time to attend high quality CPD difficult, particularly if it's a long way away.
"Webinars are already proving popular as a convenient but effective form of CPD in many sectors so I'm hoping to help the veterinary profession share the benefits they offer. Certainly my own experience is that they are easy to access and offer excellent value without the hassle of travel and late nights."
To view the webinars vets need a fixed line broadband connection, a PC with a sound card and a headset. Once payment is made, delegates are given instructions online to enable them to view the webinar they have selected.
The cost to view the whole series is £80.
Further information, including the full course schedule, is available at http://www.thewebinarvet.com/ or by contacting Anthony Chadwick on 0151 270 1759.
The RCVS Disciplinary Committee has suspended a Cardigan veterinary surgeon from the RCVS Register for five months, for failure to perform accurate bovine tuberculin testing and for falsely certifying the test results.
During the two-day hearing, Dewi Wyn Lewis, of Priory Veterinary Ltd, Cardigan, answered charges about inaccurate skin fold measurements and false certification relating to two visits he made as an Official Veterinarian to a farm in April 2009 to undertake tuberculin testing.
Mr Lewis accepted that he had not carried out the tuberculin tests in the way required by Animal Health (AH) - an Executive Agency of the Department for Environment, Food and Rural Affairs - and had taken short cuts to save time. However, he denied the charges, arguing that, although instructions to Official Veterinarians clearly required the use of callipers to measure the skin folds of cattle necks on Day One of testing, not using callipers and using his finger and thumb did not amount to failing to measure.
He also argued (and it was accepted by the Committee) that, regarding Day Two of testing, there was inconsistency in AH's instructions on calliper use, which in written form required using callipers for measuring every animal but in practice accepted use of callipers when a reaction could be detected by manually palpating the skin. On Day Two, Mr Lewis said, he had done what AH required: he had used callipers on the cattle he identified for closer examination.
The Committee, however, found that by failing to use callipers on the first day, as required by AH, Mr Lewis had failed to measure the skin folds of almost all of the 104 cattle. The Committee was also satisfied that, on the second day, 10-20% of the herd were not even touched by Mr Lewis and the Committee accepted the evidence of the three other witnesses present during the testing, which indicated that Mr Lewis had failed to carry out careful assessment and manual palpation of every animal.
The Committee then considered whether Mr Lewis had dishonestly signed the certificate, or had signed a false certificate which he ought to have known was inaccurate. The Committee noted that there were no previous Disciplinary findings against Mr Lewis, and was prepared to believe his assertion that, although he knew he had not carried out the tests in strict compliance with AH's instructions, he genuinely believed his methods to be at least as accurate as measuring with callipers and did not think he was doing anything wrong or dishonest. The Committee could not then be sure that Mr Lewis had realised what he was doing was dishonest. However, the Committee noted that 'false' also means 'inaccurate' and, as Mr Lewis ought to have known that as his testing methods were not adequate, he also should have known that a considerable number of measurements on the certificate were inaccurate and that the certificate itself was inaccurate.
After considering the facts of the case, the Committee concluded that Mr Lewis's actions amounted to serious professional misconduct and directed that he should be suspended from the Register for five months, after which he may return to practice. In relation to the sanction, the Committee said: "In reaching this decision it is relevant that the false certification was not dishonest and that there was professional and personal mitigation put forward on behalf of Mr Lewis. The Committee has paid regard to the fact that Mr Lewis is an experienced veterinary surgeon who is highly thought of in his local area. It does not believe that there is any likelihood that he will repeat his previous conduct."
The Committee also said it gave considerable weight to the fact that Mr Lewis had had to wait an additional three-month period for the hearing because of an earlier adjournment.
The following batches are affected:
Dechra is contacting wholesale dealers and asking practices to examine inventory immediately and quarantine products subject to this recall.
For further information contact Ms Carol Morgan: carol.morgan@dechra.com .
There will be 20 presentations from some of the world's leading experts, covering topics such as detection and diagnosis, advances in veterinary oncology, supportive care for the cancer patients, how to build a partnership with pet owners and, of course, feeding the cancer patient.
The presentations will be streamed live and available on demand afterwards, at https://learn.hillsvet.com/en_GB/hills-global-symposium-2023
Dr. Iveta Becvarova, Senior Director of Global Academic & Professional Affairs at Hill's Pet Nutrition said: "This year’s Hill’s Global Symposium will offer the latest advancements and innovations to help veterinary professionals support and counsel their clients, and provide the best care possible to the pets in their care."
The webinar will be presented by Marge Chandler DVM, MS, MANZCVS, DACVIM (SAIM, Nutrition), MRCVS and Dr Michael Lappin DVM, PhD, DACVIM.
Marge is an independent consultant in small animal nutrition and internal medicine and Chair of the FEDIAF Scientific Advisory Committee, founding member of the European Veterinary Nutrition Educators Group, and Co-Chair of the WSAVA Global Nutrition Committee.
Michael is the Kenneth W. Smith Professor in Small Animal Clinical Veterinary Medicine and Director of the Center for Companion Animal Studies at Colorado State University. He is on the editorial board of Feline Medicine and Surgery and Compendium on Continuing Education for the Practicing Veterinarian and is the editor of the textbook, Feline Internal Medicine Secrets.
The webinar will discuss the value supplements can offer to pets who are already on complete diets, how supplements are regulated and the importance of quality control.
The session will also cover the challenges for vets in selecting supplements for their clinical practice, what factors can determine the choice of supplement, and how you can critically evaluate the evidence supporting a supplement.
Marge and Michael will also provide tips for communicating the benefits of supplements to clients.
Daniel Rodes Moltó of the Purina Institute said: “We are pleased to offer this interactive webinar on how to evaluate and select supplements using an evidence-based approach in a non-promotional setting.
"Webinar attendees are welcome to submit questions for our speakers in advance and to ask questions during the live event, which promises to be an enjoyable and lively session supporting the aim of improving the lives of pets.”
https://webapp.spotme.com/login/eventspace/CollaborativeCareMay2023
The 2,200sqm building – equivalent to half a hockey pitch or four netball courts – will include a range of facilities across two floors. It will have two new lecture theatres, a number of IT-rich teaching and learning spaces, general teaching rooms and various environments for teaching clinical skills.
The University’s Vice-Chancellor, Dr David Llewellyn, said: "Our plans for the Veterinary School are proceeding well, with our first student intake to the new veterinary medicine course due in 2020.
"The building on the Harper Adams site will provide a great range of teaching facilities for our students, to complement the wide range of animal facilities we already have on campus. We are excited to see the progress that is being made with the Harper & Keele Veterinary School, which is generating considerable interest within the veterinary profession, and we look forward to seeing the new building take shape in the coming months."
Picture shows: Vice Chancellor Dr David Llewellyn, McPhillips’ Marketing Manager Mark Kiddie, Site Manager Ed Bickford, McPhillips’ Managing Director Paul Inions, Head of Estates and Facilities at Harper Adams University, Jonathan Cain,
Melissa, who was invested at the RCVS AGM last week, graduated from the University of Glasgow School of Veterinary Medicine in 1987, starting her career as a food animal intern at Iowa State University in the United States before moving into mixed veterinary practice in Ayrshire in 1990.
Over the next 25 years, she and her husband Kenny developed Oaks Veterinary Centre into a small animal practice with a focus on dentistry.
Melissa was first elected to Council in 2016, was re-elected in 2020 and has served on a number of committees including the Education Committee and Finance & Resources Committee.
Since 2019, she has served as Chair of the Standards Committee, leading the development of proposed new guidance on under care and out-of-hours emergency care and pain relief.
Melissa has also been President of the British Veterinary Association’s Scottish branch and the Ayrshire Veterinary Association and, outside of work, enjoys running, and caring for her dogs, cats and sheep.
In her opening speech as RCVS President, Melissa outlined her sense of community with her fellow vets, as a relatively small but prominent profession that punches above its weight, and how she intended to strengthen this as President.
Melissa said: “When I looked this up in June, there were over 300,000 doctors registered with the General Medical Council.
"We, the veterinary profession, have around 30,000 registered with the RCVS to look after farmed, pet, lab animal, exotic, zoo and wildlife species.
"In other words, all animals EXCEPT the human, and we protect humans too, with public health work!
“Even excluding farmed fish, over 300 million animals are being cared for by 30,000 professional veterinary surgeons and their teams.
"That is the scale of our small but mighty community.
"Being part of a community doesn’t mean we all have to be clones of each other, but a group that can agree to disagree, and is there for each other in times of need.
“With this close proximity to each other, communication is key.
"My mother has offered me many wise words over the years, most frequently being ‘engage brain before opening mouth’ but just as important as speaking is listening and actually hearing what is being said.
"So, over this year I will try to get out and about as much as possible, focus on hearing what our community is saying and engage in many conversations as we work together."
Compiled by global higher education analysts, QS Quacquarelli Symonds, the rankings provide a comparative analysis on the performance of 14,435 individual university programs, taken by students at 1,452 universities in 86 locations around the world, across 51 academic disciplines and five broad Faculty Areas. The rankings are determined by a range of criteria, including academic reputation, research impact, number of citations, employer reputation and the h-index.
In addition to maintaining a perfect score for the Academic Reputation indicator (100) for a second year running, the RVC saw improvements across every category. Research impact was recognised with the RVC scoring 98.9 in Citations per Paper. This was supported by the 97.5 score for h-index, surpassing 2020’s 96.9.
Rankings for Employer Reputation also increased by 29% since 2020, with the RVC now scoring 83.3.
Professor Stuart Reid, Principal of the RVC, said: "Last year, we made a commitment to redouble our efforts in seeking to regain the top spot in the QS rankings, and I am delighted that we have achieved it. This would be remarkable in normal times but, in the context of COVID-19, it is all the more so and a real tribute to the whole RVC community.
"It is the result of enormous efforts made by all RVC staff and students, and I could not be prouder to be Principal of the RVC. The QS rankings are important for our reputation and international standings. With so many outstanding veterinary schools worldwide and with peer recognition one of the metrics, it is particularly pleasing to be first amongst equals."
The full set of rankings can be found at: https://www.topuniversities.com/subject-rankings/2021
The system consists of a number of small wireless sensors which are placed in each fridge and which transmit data to a base station. It records a temperature history for each fridge, transmitting the data in real time to secure cloud storage, from where it can provide reports on the changing temperature in each fridge for compliance and regulatory purposes.
RemoteM is self-installed and battery operated, and it transmits data using the mobile phone network, so it is not reliant on a power source or working internet connection. Temperature alarms can be sent to one or more recipients, using email, automated voice calls or SMS.
Dalehead Veterinary Group, which has practices in Settle, Bentham and Gisburn, began trialling the RemoteM system almost a year ago.
Dalehead has six fridges at its Settle practice. Before installing RemoteM, practice staff needed to record daily readings of fridge temperatures, taken at different times of the day. As well as being a time-consuming process, it risked being inaccurate, as simple in-fridge monitors do not record all fluctuations in temperature.
Practice Manager Emma Spence said: "RemoteM has already saved us at least £4,000.
"One of our small animal vaccine fridges failed overnight, and the instant alarm meant we were able to respond immediately, with our on-call vet moving the stock to another fridge without risk of deterioration. At various times of year when we can have high values of stock in individual large fridges, this could have been even more critical."
The practice says the system has also proved useful in alerting staff to fluctuating temperatures in warm summer months, helping to ensure that vaccines and medicines are used in optimum condition.
For this reason, RemoteM sensors are also used outside fridges to monitor stock held at ambient temperatures, where the alarm trigger is set at 25 degrees to ensure stock does not exceed manufacturers' recommended storage temperature limits.
Another benefit of the system has been that Dalehead's insurer has said that with RemoteM, it is happy for the practice to continue to use its older fridges, instead of stipulating that they are replaced every three years.
So, it's not just saving the practice money, then. It's helping reduce pollution too.
For more information, call 0330 223 4553, email: info@remotem.co.uk or visit: www.remotem.co.uk.
The Executors of the Will of the late Mary Brancker have notified the Veterinary Benevolent Fund that she left a share of her estate to the charity.
Mary Brancker was one of only a handful of women vets when she qualified in 1937. She went on to found the Society of Women Veterinary Surgeons; became one of the first women on BVA Council and was later awarded an OBE for her services as BVA President during the century's most serious outbreaks of foot-and-mouth disease and a CBE in 2000 for services to animal health and welfare.
Mary was a long-time member of the VBF - a charity that has been run by vets for the profession for over a hundred years.
The VBF currently provides the Vet Helpline, the Veterinary Benevolent Fund, the Veterinary Surgeons' Health Support Programme and the Vetlife website. The charity says it plans to use Brancker's £40,000 bequest specifically for the redevelopment of the Vetlife website which is currently underway and for other essential support for veterinary colleagues in need. The new version of the website will be launched at the London Vet Show in November.
VBF's President Lydia Brown said: "Mary was a personal friend and her gift is so typical of her kindness and her appreciation of her career. I hope others will follow Mary's wonderful example and consider giving generously to VBF. A legacy is of enormous benefit to our charity and the veterinary profession as a whole. Although we are making every effort to adapt to the changing needs of the profession there is always more that can be done if we have sufficient funding."
Veterinary Benevolent Fund T: 020 7908 6385E: info@vetlife.org.uk
Veterinary Surgeons' Health Support ProgrammeT: 07946 634220E: VSHSP@vetlife.org.uk
Vet HelplineT: 07659 811118
See www.vetlife.org.uk for more information. Donations can be made to VBF on-line at www.virginmoneygiving.com
The RCVS has announced that the Codes of Professional Conduct for veterinary surgeons and veterinary nurses have been updated to state that you should not refer to yourselves or others as 'veterinary nurses' unless registered.
In fact, the change occurred back in June last year, but was only announced via RCVS News and as a one-liner within the 'Overview of decisions made at RCVS Council'.
The announcement raises the pretty fundamental question of what ARE veterinary surgeons and RVNs to call their unqualified colleagues, if not veterinary nurses? How indeed are those unqualified staff working in veterinary practice to describe their job title to their friends, down at the pub?
VetSurgeon.org sought to clarify the situation with the College, and the first point to make is that the new part of the CoPCs refers only to the use of the words 'veterinary nurse' when used in conjunction. The words 'nurse' or 'nursing' are not protected at all.
The College says that it is not within its remit to instruct veterinary surgeons or registered nurses as to how they should address unqualified staff, but suggested: 'Care Assistant' or 'Auxilliary'.
However, Ben Myring, RCVS Senior Policy and Public Affairs Officer said: "There is nothing to stop someone calling themselves a 'nursing assistant' or a 'head nurse'".
The Codes of Professional Conduct obviously apply only to those who are regulated by it. The title 'veterinary nurse' in unprotected in law and can therefore be used by anyone else.
So, the immediate implications seem to be as follows:
Do you have any other suggestions as to how unqualified nursing staff should be styled? Post them below.
The 2016 PAW Report, in which 4252 dog, cat and rabbit owners were surveyed by YouGov, found that 24% (an estimated 5.2M) of owners did no research at all before buying a pet.
Only 5% of prospective owners spoke with a veterinary professional before buying an animal.
This raises the question of whether practices could be doing more to engage with prospective pet owners, by offering free or low-cost pre-purchase consultations with a veterinary nurse which offer advice about suitable pets and breeds to fit with the buyer's lifestyle.
The PAW Report also discovered that 65% of prospective pet owners were unaware of the five welfare needs. Many also dramatically underestimate the financial implications of owning a pet with 12% of owners believing their pet would only cost up to £500 over their entire lifetime. Overall, 98% of respondents underestimated the lifetime cost of owning their pet to some degree.
Buying pets from inappropriate sources was another major concern, with 23% of veterinary professionals identifying this as one of most critical issues which they would choose to resolve tomorrow. 50% of owners said they would consider getting a pet from a private, classified online advert. 18% of owners said they would still consider getting a puppy from a puppy farm, while others would consider getting a pet from an advert posted on social media (37%), from a pet supermarket (41%), or a pet that has been imported from abroad (28%).
A pre-purchase consultation could help address all of these issues, helping to set the owner's expectations about costs, educate them about the five welfare needs and steer them in the direction of reputable source to buy their new pet.
Such consultations would obviously need to be marketed beyond existing clients in the waiting room, but could be added to existing marketing materials used in the local media and added to the practice website ('Thinking of buying a pet, talk to us first').
To help practices that want to engage with potential pet owners in this way, the PDSA has launched a free ‘Which Pet?’ consultation framework for veterinary teams. The materials include client and explanatory vet team booklets, marketing materials and an e-learning CPD module. They can all be accessed free of charge on PDSA’s website at: pdsa.org.uk/whichpet
Commenting on the PAW Report findings, Sean Wensley, PDSA senior veterinary surgeon, said: "There is little doubt that we’re a nation of animal-lovers. But the PAW Report highlights that impulse-buying pets is still an issue of great concern, and shows no signs of improving. Little or no research before getting a pet means owners have limited understanding of what their pets require throughout their lives, which is undoubtedly leading to an array of other troubling pet welfare problems."
Other key findings:
Dechra says the ability to split Prednicortone into 1.25 mg doses is particularly useful when used alongside Zycortal, the only licensed treatment for canine Addison’s disease in Europe.
Dechra Brand Manager Carol Morgan said: "Dogs with primary Addison’s disease have insufficient levels of natural mineralocorticoids (primarily aldosterone) and glucocorticoids (primarily cortisol). Zycortal contains DOCP, a synthetically produced steroid hormone, which acts in a similar way to aldosterone.
"It causes sodium retention and potassium excretion, helping to maintain water balance but Zycortal only replaces the mineralocorticoid. Therefore, a daily oral glucocorticoid treatment, such as Prednicortone, is needed to address the cortisol deficiency, alongside Zycortal.
"The amount of glucocorticoid administered should be adjusted to the individual dog’s need and it is likely that the dose required will be reduced over time."
She added that a combined approach of Zycortal and Prednicortone allowed independent dose titration of both mineralocorticoids and glucocorticoids.
"The advantage of prescribing the two treatments is that the dosage for each component can be tailored to an individual animal’s response. This leads to a reduction in the side effects usually associated with over-supplementation of glucocorticoids."
There are 250 tablets in a pack and Prednicortone offers accurate dosing using a double divisible SmartTab format and accurate dispensing via blister packs. The flavoured tablets also encourage easy oral administration.
For more information, visit www.dechra.co.uk.
Intervet/Schering-Plough Animal Health has launched Posatex (1% Orbifloxacin, 0.1% Mometasone Furoate Monohydrate and 0.1% Posaconazole, Otic Suspension), a new once-a-day treatment for otitis externa in dogs.
Posatex combines an antibacterial, an anti-inflammatory and an antifungal medication in one, seven-day treatment which the company describes as the 'next generation' treatment for severe otitis externa in dogs, designed to make compliance easier and bring fast relief to dogs suffering from this painful condition.
Allan Weingarten, Director, Pharmaceutical Research, and Posatex R&D Project Leader, said: "As every dog owner knows, this is a 'nightmare' disease. As experts in otic products, we feel a special responsibility to keep improving medications and continuing to make the course of treatment more effective, quicker and easier for both dogs and their caregivers. The novel triazole antifungal posaconazole, new to animal health, is the latest example of innovation in this product area."
Posatex Otic Suspension, available in 7.5, 15 and 30g plastic bottles, is indicated for the treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (coagulase positive staphylococci, Pseudomonas aeruginosa and Enterococcus faecalis).
According to the company, posaconazole, the newest element in the three-in-one combination, has been shown to be particularly effective against Malassezia pachydermatis and more potent than other veterinary antifungals. Mometasone furoate monohydrate is a potent and safe anti-inflammatory and Orbifloxacin is a broad-spectrum antibiotic with proven efficacy against bacteria.
Procapen contains a high dose of procaine benzyl penicillin, a narrow spectrum antibiotic which targets the most important pathogens in fresh cases of mastitis in cows and is the drug of choice against benzylpenicillin-susceptible streptococci and staphlococci.
Marcus Scott, Large Animal Business Manager at Forte said: "With the widespread shortage of intramammary tubes at the moment, Procapen provides a welcome solution for many mastitis cases."
For more information, contact your local Forte Territory Manager or email: enquiries@fortehealthcare.com.
Tramadol has become a controlled drug and has been added to Schedule 3 of the Misuse of Drugs Regulations 2001
The change to the regulations, which was made by the Home Office means that the drug is now subject to special requirements when writing prescriptions.
The RCVS says practitioners should also note that:
Although tramadol is exempt from Safe Custody Regulations, the RCVS advises that all Schedule 3 controlled drugs are locked away.
The Home Office has also reclassified ketamine as a Class B controlled drug. However, it remains under Schedule 4 (Part 1) of the 2001 Regulations meaning that the legal requirements for supply, storage and record keeping remain the same.
The RCVS therefore continues to advise that practice premises should:
Further details about the specific requirements for controlled drugs can be found in the Veterinary Medicines Directorate’s Guidance Note No 20 – Controlled Drugs.
Practice premises can also contact the RCVS Professional Conduct Department for further guidance on 020 7202 0789 or profcon@rcvs.org.uk.
The International Society of Feline Medicine (ISFM), the veterinary division of International Cat Care, has published Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats to help veterinary teams deliver optimal management for the diabetic cats presented in practice.
The guidelines were produced by an expert panel of veterinary clinicians and academics who reviewed clinical research studies to collate the best available evidence. They've been published in the March 2015 issue of the Journal of Feline Medicine and Surgery (JFMS) and are available to download free from http://jfm.sagepub.com/content/17/3/235.full.pdf+html.
The guidelines focus on the most important aspects of managing diabetic cats including weight control, use of an appropriate diet, insulin therapy (highlighting the value of longer acting insulin preparations) and close monitoring of blood glucose concentrations (including in the home environment).
The ISFM says the guidelines recognise that good diabetic control requires a long-term commitment and one of the keys to success is finding a treatment protocol that best fits in with owners' daily lives. Furthermore, owners may give up on treatment, or even elect for euthanasia of the cat, if the disease impacts too negatively on them and their relationship with their cat. However, with appropriate support and guidance from their veterinary practice, an owner can play an invaluable role in managing diabetes. A well-regulated cat will have a better prognosis and may also be more likely to go into diabetic remission, no longer requiring ongoing insulin therapy.
Among the resources available to assist owners of diabetic cats is a series of short videos produced by International Cat Care (available at http://www.youtube.com/iCatCare) demonstrating blood glucose sampling, insulin injection, and urine collection and testing.
Reference
Royal Canin has announced the launch of a summer campaign to help small animal practices develop their relationships with cat-owning clients.
'Summer of the Cat' runs throughout July, August and September. As part of the campaign, cat owners are being invited to share adventures their cat has over the summer with their vet practice, for the chance to win a year's supply of Royal Canin cat food.
Entry forms, which contain spaces for photos and drawings, will be distributed to practices along with other promotional materials such as balloons, posters, bunting, tent cards and wobblers.
The competition - which also gives entrants the chance to win large A3 posters of their 'Summer of the Cat' storyboards - is being supported by a promotional offer to 'feed your cat free for a week' from July to September.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers will be able to buy any 1.5 - 2kg bag of feline Veterinary Care Nutrition from their vet and get a 400g bag free. Those cat owners taking up the offer will also receive a money off voucher (£3/€4) for their next purchase to encourage loyalty and increased footfall in the participating vet practices."
For more information, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
Dr Sabela Atencia DVM MVM Dip-ECVIM CA MRCVS is an internal medicine specialist who holds the European Diploma in Small Animal Internal Medicine.
During her research for her Masters degree on muscular dystrophy in the Japanese Spitz breed, she contributed to knowledge of the underlying mutation of the disease, facilitating the development of a genetic test.
Sabela enjoys all aspects of canine and feline Internal Medicine, but is particularly interested in endoscopy, endocrinology and genetics.
Dr Owen Davies MA VetMB MVetMed MANZCVS(SAM) MRCVS, a veterinary medical oncology clinician, holds a Masters degree based on research into canine lymphoma.
Owen is interested in all aspects of medical oncology, especially haematopoietic malignancies, targeted therapy for cancer and paraneoplastic disease. He has recently completed a residency in veterinary oncology at the Royal Veterinary College and has just passed the DACVIM examinations in Oncology.
Dr Elisabetta Mancinelli DVM CertZooMed Dipl ECZM (Small Mammal) MRCVS is a European Veterinary Specialist in Zoological Medicine (Small Mammal Medicine and Surgery) and an RCVS Recognised Specialist in Zoo and Wildlife Medicine.
She was the first veterinary surgeon to undertake the European College of Zoological Medicine (ECZM) Residency in Small Mammal Medicine, which she completed at The Royal (Dick) School of Veterinary Studies, Edinburgh.
Elisabetta will lead and further expand the established exotic pet service at the Hospital.
Acting Hospital Director, Professor Stuart Carmichael said: "As we continue to extend the range of services and expertise we offer to our clients, we are delighted to welcome these three distinguished professionals to the team here at Highcroft. They will make a great contribution and it’s great to have them aboard."
Highcroft Veterinary Referrals is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
Photo: Left to right: Dr Elisabetta Mancinelli, Dr Owen Davies, Dr Sabela Atencia
Joii has announced that its free vet nurse consultations and £20 consultations with veterinary surgeons will now be available 24 hours a day. The out-of-hours service will be delivered by eight UK-trained vets based overseas in countries such as Australia, to ensure its UK-based staff continue to enjoy a healthy work-life balance with no interruptions from nighttime working.
Meanwhile FirstVet has announced that for the next six weeks, all consultations via its platform will be free of charge. Appointments will be available for five hours per day, from 12:00pm to 5:00pm.
Veterinary practices that wish to provide their own online consultations have a couple of options to consider: The Virtual Vet Group, and VetHelpDirect.
The RCVS Disciplinary Committee has directed that a veterinary surgeon from Berkshire be removed from the Register, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a six-day hearing that concluded yesterday, James Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury, and former lead veterinary surgeon to racehorse trainer Nicky Henderson, faced four charges of serious professional misconduct concerning his treatment of Moonlit Path, a six-year-old mare owned by The Queen.
Three of the charges related to Mr Main breaching British Horseracing Authority (BHA) rules by injecting Moonlit Path with tranexamic acid (TA) on the day she was due to race; the fourth charge related to his dishonest concealment of this treatment in his practice clinical records. Nicky Henderson had himself faced a BHA Inquiry into this case in 2009 and subsequently been sanctioned.
The Committee heard that on 18 February 2009, Mr Henderson's yard requested a veterinary surgeon attend Moonlit Path to administer an injection of Dycenene the following morning. The injection was requested as the mare was prone to exercise-induced pulmonary haemorrhage. Mr Main attended on the morning of 19 February and injected the horse with intravenous tranexamic acid. Moonlit Path raced at Huntingdon later that day, along with the eventual winner, and favourite, Ravello Bay - another horse trained by Mr Henderson. Moonlit Path finished sixth and a urine sample taken from her after the race tested positive for TA.
Of the four charges, Mr Main admitted injecting Moonlit Path with TA on the day she was due to race when he knew this breached the BHA's rule prohibiting any substance other than the horse's usual feed and water being given on race day. However, Mr Main denied knowing that, if tested, a horse would test positive for TA (thereby imposing a strict liability on the trainer); he denied administering a prohibited substance to a horse with the intention to affect that horse's racing performance; and, he denied dishonestly concealing the TA injection by omitting it from his clinical records and referring to it as a 'pre-race check'.
The Committee heard and carefully considered evidence from Mr Henderson and his employees, from BHA investigating officers and its Director of Equine Science and Welfare, from an expert equine physiologist and from Mr Main himself. In its findings, the Committee stated it was "unimpressed by Mr Henderson's evidence and surprised by his apparent lack of knowledge of the rules of racing".
Whilst the Committee accepted Mr Main believed at the time that Moonlit Path would not test positive for TA, it considered he failed to fully inform himself of the medicinal product he was using; especially so as TA does not possess a Marketing Authorisation as a veterinary medicinal product. In so doing, he did not meet his professional obligation to provide Mr Henderson with the information and advice he needed.
The Committee concluded that TA was a prohibited substance and, whilst accepting that Mr Main's concern had solely been for Moonlit Path's welfare, he had actually breached BHA rules by affecting her performance through administering such a substance.
Finally, the Committee found that Mr Main had deliberately concealed the TA injection to Moonlit Path by describing it in his notes as a 'pre-race check' - a protocol developed over several years between the practice and Mr Henderson. Such inaccurate clinical records were in breach of the RCVS Guide to Professional Conduct and led the Committee to conclude he had acted dishonestly. The Committee also found Mr Main "did not act with candour" by claiming to have administered the TA injection the day before the race. On questioning by the Legal Assessor, however, he admitted that he had known that Moonlit Path was racing the same day that he administered the injection.
Professor Sheila Crispin, chairing the Committee, said: "[We] regard it as wholly unacceptable practice that a veterinary surgeon should be party to serious breaches of rules of another regulatory body in the field of animal welfare ... and which go to the very integrity of racing.
"Whilst the findings relate to a single incident, [we] are satisfied that Mr Main's actions amounted to pre-meditated misconduct ... It is highly relevant that Mr Main held positions of responsibility within the racing industry where he was required to uphold the rules and standards of the profession," she added.
Noting Mr Main's "long and hitherto unblemished career as a highly respected equine veterinary surgeon", the Committee accepted Mr Main's evidence that the reason for the administration of tranexamic acid was solely his concern about the welfare of the horse. Nevertheless, it found his evidence was "evasive, lacking in candour and on some aspects of the case his evidence was untrue".
Professor Crispin concluded: "...proven dishonesty has been held to come at the top end of the spectrum of gravity of disgraceful conduct in a professional respect ... Having considered carefully all the mitigation put forward on Mr Main's behalf, [we] have concluded that Mr Main's behaviour was wholly unacceptable and so serious that removal of his name from the Register is required."
Boehringer Ingelheim Vetmedica has launched Pexion (imepitoin) a novel treatment for canine idiopathic epilepsy.
Canine epilepsy can affect up to 5% of dogs6. In most dogs diagnosed with idiopathic epilepsy no underlying cause for the seizures can be found. While the condition can affect any dog, it is more common in young (one to five year old), purebred dogs such as Labradors, Golden Retrievers, German Shepherds, Boxers, Vizlas, Beagles, English Springer Spaniels, Irish Setters, Poodles and Dachshunds.
Boehringer says Pexion has a highly targeted mode of action1-3 to suppress a dog's seizures. It starts to work within a few hours and reaches steady state within three days4,5. Boehringer claims this will make it easier to stabilise epileptic patients. It also says there is no evidence of hepatotoxicity or liver-associated enzyme elevation, so repeated blood tests for liver enzymes or therapeutic levels are no longer required.4,5
Pexion is available in 100 mg and 400 mg tablets. The tablets are white, scored and divisible in half. Both tablet strengths are available in 100 tablet packs from veterinary wholesalers.
Jemima Mead, brand manager at Boehringer said: "Pexion is a ground-breaking new product which gives vets a new first-line treatment option for dogs with idiopathic epilepsy, improving the lives of newly diagnosed epileptic dogs and their owners by reducing the number of seizures and their impact on the patient's life".
To support the launch of the new product, Boehringer hosted an epilepsy webinar presented by neurologist Dr Holger Volk DVM PhD DipECVN FHEA MRCVS, recognised RCVS and European Specialist in Veterinary Neurology. The webinar is now available on demand at www.bi-academy.co.uk.
For further information on Pexion visit www.pexion.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
References